Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
608 participants
OBSERVATIONAL
2024-09-01
2025-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Specifically, the ZEPHYR study is a cross-sectional (cross-sectional), population-based, multicenter survey. The centers involved are the ASL of Taranto with the Taranto City Single District (Coordinating Recruitment Center), the University of Hasselt, Belgium (Recruitment Center Hasselt Hospital Campus), and the University of Krakow, Poland (Rybnik University Hospital as recruitment center).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Healthy Communities: a Healthy City Preventive Program on Cardiovascular Health and Well-being (HC)
NCT05974826
Health-related Quality of Life in Patients at Nordic Clinic
NCT04611074
Analysis of the Efficiency of a Chronic Disease Self-Management Programme in a Vulnerable Population in Five European Countries
NCT03840447
Impact of the Social Determinants of Health in the Central Catalan Region
NCT04151056
Multimorbidity Management Supported by a Digital Platform
NCT05593835
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Recruitment of 380 children, 418 adults and 418 elderly. These sample sizes will be those planned for each unit (Taranto in Italy, Rybnik in Poland, and Genk-Hasselt County in Belgium).
2. The areas of Tamburi (an area presumably highly exposed to environmental pollutants) and Talsano-Lama-San Vito will be selected for sampling in the city of Taranto.
3. Administration of informed consents through general practitioners and pediatricians of free choice in the areas involved in recruitment.
4. Collection of urine and blood samples to measure determinants associated with the concentration of black carbon (BC) in urine samples and other pollutants (PCBs, Benzene) in blood and urine. The collected exposure data will be used to create a pragmatic score (dose-response function) of environmental pollution contamination.
5. Measurement of clinical, social and environmental determinants and predictors of quality of life (QoL), measured using a specific validated multinational questionnaire the EQ-5D-5L, and to create a probabilistic score, using feature selection algorithms in machine learning, that can predict different classes of QoL using clinical, social and environmental determinants.
Black carbon assay will be considered as a proxy for exposure to pollutants specifically related to steel production. This has been identified as one of the most promising biomarkers in terms of evidence of both deterministic and stochastic biological damage, in particular in the pediatric population,3 and it has even been demonstrated in fetal exposure4. In addition, the huge amount of urine samples collected will lead to the creation of a urine biobank for further (eventual) molecular analysis. Quality of life will be measured directly in different subpopulations, to be used to construct individual surrogate QALY scores.
On the sidelines of these macro objectives, however, additional biomarkers will be analyzed in the tissues of consenting subjects.
Specifically, the following will be analyzed :
1. Benzene metabolites: S-phenyl-mercapturic acid (SPMA)c,t- muconic acids;
2. metabolites of PAHs: the 1-hydroxypyrene (1-OHPyr)
3. cotinine to identify smokers, those exposed to secondhand smoke, and in nonsmokers.
4. PCR analysis for detection of telomere length (indicators of aging)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lifestyle factors
introduction of environmental risk mitigation policies, from data and evidence from case studies (several European cities) with different levels of exposure to environmental, health, geographic, and socioeconomic factors.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Taranto people residing outside the above areas
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Azienda Sanitaria Locale di Taranto
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Roberta Zupo
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Local Health Authority of Taranto
Taranto, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
MISTRAL project
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
01/2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.